| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/18/2011 | US7871614 Gold-binding protein and use thereof |
| 01/18/2011 | US7871613 Adjuvant therapy with the use of anti-glypican 3 antibody |
| 01/18/2011 | US7871612 Using sialoadhesin specific immunoglobulin as diagnostic and/or therapeutic tool in treatment and prevention of allergic, respiratory, cell proliferative and skin disorders |
| 01/18/2011 | US7871610 Antibodies to Tie1 ectodomain |
| 01/18/2011 | CA2637795C Antagonists of interleukin-15 |
| 01/18/2011 | CA2519408C High concentration antibody and protein formulations |
| 01/18/2011 | CA2455145C Pregnancy-related serine protease |
| 01/18/2011 | CA2385444C Humanin, a polypeptide suppressing neuronal death |
| 01/18/2011 | CA2191053C A fusion protein comprising a furin derivative or a derivative of a furin analogue and a heterlogous sequence |
| 01/18/2011 | CA2156976C Genetic sequences encoding glucocorticoid dehydrogenases and uses therefor |
| 01/13/2011 | WO2011005715A1 Diagnosis and treatment of autoimmune demyelinating diseases |
| 01/13/2011 | WO2011005621A1 Design of stable and aggregation free antibody fc molecules through ch3 domain interface engineering |
| 01/13/2011 | WO2011004899A1 Cancerous disease modifying antibodies |
| 01/13/2011 | WO2011004847A1 NOVEL HUMANIZED ANTI-HUMAN α9-INTEGRIN ANTIBODY |
| 01/13/2011 | WO2011004837A1 Antibody having anti-cancer activity |
| 01/13/2011 | WO2011004379A1 Compositions and methods for treating cancer |
| 01/13/2011 | WO2011004192A1 Animal models and therapeutic molecules |
| 01/13/2011 | WO2011004028A2 Tlr3 binding agents |
| 01/13/2011 | WO2011003996A1 In vivo tumor vasculature imaging |
| 01/13/2011 | WO2011003984A1 Means and methods for detecting and identifying a novel bacterium responsible for phytosanitary disorders in plants (zucchini) and novel resistant plants |
| 01/13/2011 | WO2011003925A1 Humanised antibodies to toll-like receptor 2 and uses thereof |
| 01/13/2011 | WO2011003896A1 Detection and visualization of the cell cycle in living cells |
| 01/13/2011 | WO2011003811A1 Stabilized immunoglobulin constant domains |
| 01/13/2011 | WO2011003809A1 Role of pld1 in thrombus formation and integrin alpha iib beta 3 activation |
| 01/13/2011 | WO2011003780A1 Bi-specific digoxigenin binding antibodies |
| 01/13/2011 | WO2011003622A1 Method for the production of variable domains |
| 01/13/2011 | WO2011003557A1 A complex of bi-specific antibody and digoxigenin conjugated to a therapeutic or diagnostic agent |
| 01/13/2011 | WO2011003369A1 New tumor marker |
| 01/13/2011 | WO2011003138A1 Immunomodulating compositions comprising interleukin 13 inhibitors and uses therefor |
| 01/13/2011 | WO2010135411A3 Aurora-a copy number and sensitivity to inhibitors |
| 01/13/2011 | WO2010132697A3 Methods and compositions for treatment |
| 01/13/2011 | WO2010120514A3 Antigen-binding proteins comprising recombinant protein scaffolds |
| 01/13/2011 | WO2010094722A3 Improved anti-serum albumin binding variants |
| 01/13/2011 | WO2010094720A3 Improved anti-tnfr1 polypeptides, antibody variable domains & antagonists |
| 01/13/2011 | WO2010066835A3 Eph receptor and ephrin ligand specific vhh antibodies |
| 01/13/2011 | WO2010043650A3 Amino acid sequences targeting human cd4, cxcr4, ccr5, tlr4, alphav integrin, beta3- integrin, betal -integrin, human alpha2- integrin, cd81, sr-bi, claudin-i, claudin-6 and claudin-9, respectively, and neutralizing viral entry |
| 01/13/2011 | WO2009140684A3 Use of biomarkers for assessing treatment of gastrointestinal inflammatory disorders with beta7integrin antagonists |
| 01/13/2011 | US20110010807 Starch branching enzyme |
| 01/13/2011 | US20110010803 Polypeptides, Such As Lipases, Capable Of Altering The Seed Storage Content In Transgenic Plants |
| 01/13/2011 | US20110010800 Plants with increased yield |
| 01/13/2011 | US20110010780 Kcnn3 as diagnostic and therapeutic target for neurodegenerative diseases |
| 01/13/2011 | US20110009602 Human cd28 specific monoclonal antibodies for antigen-nonspecific activation of t-lymphocytes |
| 01/13/2011 | US20110009601 Labeled protein and method for obtaining the same |
| 01/13/2011 | US20110009600 Recombinant Antibody Composition |
| 01/13/2011 | US20110009599 Apo-2 receptor polypeptides |
| 01/13/2011 | US20110009323 Non-immunoglobulin antigen binding scaffolds for inhibiting angiogenesis and tumor growth |
| 01/13/2011 | US20110009319 Cripto antagonism of activin and tgf-b signaling |
| 01/13/2011 | US20110009293 Nonseparation Assay Methods |
| 01/13/2011 | US20110008900 Depletion of plasma proteins |
| 01/13/2011 | US20110008840 Anti-cd33 antibodies and methods for treatment of acute myeloid leukemia using the same |
| 01/13/2011 | US20110008808 Biomarkers |
| 01/13/2011 | US20110008795 Marker for detection of il-17-producing helper t-cell, and method for detection of il-17-producing helper t-cell |
| 01/13/2011 | US20110008789 Methods and materials for treating inflammatory conditions |
| 01/13/2011 | US20110008786 Methods of detecting and controlling mucoid pseudomonas biofilm production |
| 01/13/2011 | US20110008769 Dopaminergic neuron progenitor cell marker 187a5 |
| 01/13/2011 | US20110008766 Dual Variable Domain Immunoglobulins and Uses Thereof |
| 01/13/2011 | US20110008523 Genetic sequences having methyltransferase activity and uses therefor |
| 01/13/2011 | US20110008452 Medicinal agent for treating fatness, diabetes, and diseases associated with impaired glucose tolerance |
| 01/13/2011 | US20110008414 Method for synthesizing conformationally constrained peptides, peptidomimetics and the use thereof as synthetic vaccines |
| 01/13/2011 | US20110008393 Nucleic acids and corresponding proteins entitled 58p1d12 useful in treatment and detection of cancer |
| 01/13/2011 | US20110008389 Recombinant attenuated clostridium organisms and vaccine |
| 01/13/2011 | US20110008380 Anaplasma Phagocytophilum (Aph) Antigens and Antibodies Specific for Anaplasma |
| 01/13/2011 | US20110008373 Prodrugs of cc-1065 analogs |
| 01/13/2011 | US20110008370 Novel use of flj25416 gene |
| 01/13/2011 | US20110008369 Pd-1 binding proteins |
| 01/13/2011 | US20110008367 Anti-vegf antibody |
| 01/13/2011 | US20110008366 Inhibition of versican with sirna and other molecules |
| 01/13/2011 | US20110008364 Antibodies to tgf-beta |
| 01/13/2011 | US20110008363 Erythropoietin variants |
| 01/13/2011 | US20110008360 Human antibodies against rabies and uses thereof |
| 01/13/2011 | US20110008359 Monoclonal antibodies against angptl4 |
| 01/13/2011 | US20110008358 Human monoclonal antibodies that specifically bind igf-ii |
| 01/13/2011 | US20110008357 Antibodies that bind il-18 and methods of inhibiting il-18 activity |
| 01/13/2011 | US20110008356 Il-17 heteromeric receptor complex |
| 01/13/2011 | US20110008355 Anti-flt3 antibodies |
| 01/13/2011 | US20110008354 Antibodies to apo-2 receptor polypeptides |
| 01/13/2011 | US20110008353 Identification of astrovirus va1 associated with gastroenteritis in humans |
| 01/13/2011 | US20110008352 Toll-Like Receptor 3 Antagonists |
| 01/13/2011 | US20110008351 Anticomplement polypeptides of ixodes ricinus |
| 01/13/2011 | US20110008348 Soluble fragments of influenza virus pb2 protein capable of binding rna-cap |
| 01/13/2011 | US20110008346 Biomarkers for cardiovascular disease |
| 01/13/2011 | US20110008345 Antigen-binding constructs |
| 01/13/2011 | US20110008344 Fusion partner cell line for preparation of hybrid cells expressing human antibodies |
| 01/13/2011 | US20110008342 Compositions of humanized notch fusion proteins and methods of treatment |
| 01/13/2011 | US20110008339 Monoclonal antibody and use thereof |
| 01/13/2011 | US20110008338 Treatment of Autoimmune Diseases |
| 01/13/2011 | US20110008337 Treatment of Autoimmune Diseases |
| 01/13/2011 | US20110008336 Treatment of Autoimmune Diseases |
| 01/13/2011 | US20110008335 Methods and Compositions for Increasing the Efficiency of Therapeutic Antibodies Using NK Cell Potentiating Compounds |
| 01/13/2011 | US20110008334 Nogo-a binding with enhanced affinity and pharmaceutical use thereof |
| 01/13/2011 | US20110008333 Methods of inhibiting unwanted cell proliferation using hedgehog antagonists |
| 01/13/2011 | US20110008330 Compositions and methods of tolerizing a primate to an antigen |
| 01/13/2011 | US20110008329 Methods of Treating RSV Infections And Related Conditions |
| 01/13/2011 | US20110008326 Binding agents directed against il-4 receptor for the treatment of tumors, inflammatory and immunological disorders |
| 01/13/2011 | US20110008324 Antibody Selective for a Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor and Uses Thereof |
| 01/13/2011 | US20110008323 Cadherin-11 EC1 Domain Antagonists for Treating Inflammatory Joint Disorders |
| 01/13/2011 | US20110008321 Vectors, Host Cells, and Methods of Production and Uses |
| 01/13/2011 | US20110008302 Compositions and methods for immortalizing cells and screening for anti-cancer agents |
| 01/13/2011 | US20110008292 Lactobacillus acidophilus nucleic acids encoding fructo-oligosaccharide utilization compounds and uses thereof |
| 01/13/2011 | US20110008256 Monoclonal antibodies that bind or neutralize dengue virus |